Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

Abstract Background The aim of this study was to investigate the effectiveness and tolerability of the combination elvitegravir/cobicistat/tenofovir/emtricitabine plus darunavir (EVG/COB/TFV/FTC + DRV) in treatment-experienced patients from the cohort of the Spanish HIV/AIDS Research Network (CoRIS)...

Full description

Bibliographic Details
Main Authors: Inés Suárez-García, Cristina Moreno, Marta Ruiz-Algueró, María Jesús Pérez-Elías, Marta Navarro, Marcos Díez Martínez, Pompeyo Viciana, Laura Pérez-Martínez, Miguel Górgolas, Concha Amador, Miguel Alberto de Zárraga, Inma Jarrín, the Cohort of the Spanish HIV/AIDS Research Network (CoRIS)
Format: Article
Language:English
Published: BMC 2020-07-01
Series:AIDS Research and Therapy
Subjects:
HIV infection
Highly active antiretroviral therapy
Cohort studies
Darunavir
Online Access:http://link.springer.com/article/10.1186/s12981-020-00302-2

Internet

http://link.springer.com/article/10.1186/s12981-020-00302-2

Similar Items